A detailed history of Harfst & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Harfst & Associates, Inc. holds 12,875 shares of JNJ stock, worth $2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
12,875
Previous 12,936 0.47%
Holding current value
$2 Million
Previous $1.89 Million 10.37%
% of portfolio
0.47%
Previous 0.44%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$145.48 - $167.38 $8,874 - $10,210
-61 Reduced 0.47%
12,875 $2.09 Million
Q2 2024

Aug 01, 2024

BUY
$144.38 - $157.78 $45,912 - $50,174
318 Added 2.52%
12,936 $1.89 Million
Q1 2024

Aug 01, 2024

BUY
$155.22 - $162.74 $1.96 Million - $2.05 Million
12,618 New
12,618 $2 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $28,392 - $30,981
-195 Reduced 1.74%
10,987 $1.72 Million
Q3 2023

Nov 07, 2023

SELL
$155.75 - $174.48 $240,945 - $269,920
-1,547 Reduced 12.15%
11,182 $1.74 Million
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $116,071 - $124,914
752 Added 6.28%
12,729 $2.11 Million
Q1 2023

May 10, 2023

BUY
$151.05 - $180.26 $224,309 - $267,686
1,485 Added 14.15%
11,977 $1.86 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $30,437 - $34,160
190 Added 1.84%
10,492 $1.85 Million
Q3 2022

Oct 27, 2022

BUY
$161.33 - $179.52 $339,922 - $378,248
2,107 Added 25.71%
10,302 $1.68 Million
Q2 2022

Jul 28, 2022

BUY
$168.19 - $186.01 $223,188 - $246,835
1,327 Added 19.32%
8,195 $1.45 Million
Q1 2022

Apr 28, 2022

BUY
$158.14 - $179.59 $51,869 - $58,905
328 Added 5.02%
6,868 $1.22 Million
Q4 2021

Feb 07, 2022

BUY
$155.93 - $173.01 $81,395 - $90,311
522 Added 8.67%
6,540 $1.12 Million
Q3 2021

Oct 28, 2021

BUY
$161.5 - $179.47 $13,566 - $15,075
84 Added 1.42%
6,018 $971,000
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $82,610 - $88,614
518 Added 9.56%
5,934 $977,000
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $76,841 - $85,580
502 Added 10.22%
5,416 $890,000
Q4 2020

Jan 25, 2021

BUY
$137.11 - $157.38 $13,025 - $14,951
95 Added 1.97%
4,914 $773,000
Q3 2020

Nov 04, 2020

SELL
$140.38 - $153.83 $20,916 - $22,920
-149 Reduced 3.0%
4,819 $717,000
Q2 2020

Aug 07, 2020

SELL
$128.81 - $155.51 $7,986 - $9,641
-62 Reduced 1.23%
4,968 $698,000
Q1 2020

May 05, 2020

SELL
$111.14 - $153.99 $2,778 - $3,849
-25 Reduced 0.49%
5,030 $659,000
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $28,560 - $32,802
224 Added 4.64%
5,055 $737,000
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $10,029 - $11,229
-79 Reduced 1.61%
4,831 $625,000
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $35,279 - $38,800
269 Added 5.8%
4,910 $683,000
Q1 2019

May 01, 2019

BUY
$125.72 - $139.79 $59,842 - $66,540
476 Added 11.43%
4,641 $648,000
Q4 2018

Feb 06, 2019

BUY
$122.84 - $147.84 $36,114 - $43,464
294 Added 7.59%
4,165 $537,000
Q3 2018

Oct 31, 2018

BUY
$121.58 - $142.88 $27,355 - $32,148
225 Added 6.17%
3,871 $534,000
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $8,596 - $9,486
72 Added 2.01%
3,646 $442,000
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $1,251 - $1,481
10 Added 0.28%
3,574 $458,000
Q3 2017

Nov 07, 2017

BUY
$129.47 - $135.38 $11,781 - $12,319
91 Added 2.62%
3,564 $463,000
Q2 2017

Aug 11, 2017

BUY
N/A
3,473
3,473 $459,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Harfst & Associates, Inc. Portfolio

Follow Harfst & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harfst & Associates, Inc. with notifications on news.